[{"title": "Artificial intelligence in cardiology: Present state and prospective directions", "link": "https://www.sciencedirect.com/science/article/pii/S1687850724001961", "details": "Y Alharbi - Journal of Radiation Research and Applied Sciences, 2024", "abstract": "Artificial intelligence (AI) is a fast-growing technology that has great potential for advancements in cardiovascular medicine. Cardiovascular diseases (CVDs) are currently diagnosed through a comprehensive patient evaluation that includes a \u2026"}, {"title": "Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes, Transgenic Rabbits \u2026", "link": "https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.124.068959", "details": "L Crotti, R Neves, F Dagradi, G Musu, F Giannetti\u2026 - Circulation, 2024", "abstract": "BACKGROUND: Despite major advances in the clinical management of long QT syndrome, some patients are not fully protected by beta-blocker therapy. Mexiletine is a well-known sodium channel blocker, with proven efficacy in patients with sodium \u2026"}, {"title": "Continuous Atrial Fibrillation Monitoring From Photoplethysmography", "link": "https://www.amps-llc.com/uploads/2024-6-25/Pavel%2520on%2520PPG.pdf", "details": "P Antiperovitch, D Mortara, J Barrios, R Avram, K Yee\u2026 - 2024", "abstract": "ABSTRACT BACKGROUND Continuous monitoring for atrial fibrillation (AF) using photoplethysmography (PPG) from smartwatches or other wearables is challenging due to periods of poor signal quality during motion or suboptimal wearing. As a \u2026"}]
